Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Stud Fam Plann. 2021 Feb 2;52(1):3–22. doi: 10.1111/sifp.12144

TABLE 4.

Effects of access and free access to a broad contraceptive method mix

(1) (2) (3)
All women Current contraceptive users
Modern Contraceptive Use LARC Use Decision-Making
Access to both LARC and SARC 0.021
[−0.007,0.049]
0.055
[−0.007,0.116]
0.014
[−0.020,0.049]
Free access to both LARC and SARC 0.047**
[0.019,0.074]
0.004
[−0.055,0.062]
0.014
[−0.020,0.047]
p-value 0.004 0.027 0.663
Control mean 0.252 0.282 0.906
Number of observations 29802 8462 8462

95% confidence intervals in brackets

LARC: long-acting reversible contraceptives, including implants and intrauterine devices. SARC: short-acting reversible contraceptives. Decision-making: whether respondent participated in the decision on contraceptive method. Propensity weights generated from multinomial logistic models were applied to adjust for observed differences by treatment status. The p-value row reports the two-sided p-value from an F-test of equality of the treatment effects of access and free access.

*

p < 0.05,

**

p < 0.01,

***

p < 0.001